Mitsu Mitragynine + Pseudoindoxyl Tablet (55mg + 8mg) Price range: $19.00 through $249.00Select options
25,000
Customers
175,000
Shipped
Fire 7s – 7-OH Tablets (19mg)
Mitsu Mitragynine + Pseudoindoxyl Tablet (55mg + 8mg)
Mitsu brings together 55mg of Mitragynine and 8mg of Pseudoindoxyl in a single, precisely defined tablet.
Built around clarity and composition transparency, Mitsu presents a bold compound profile in a streamlined format with a clean finish and subtle blue-toned profile. The structure is compact, direct, and unmistakably intentional.
Price range: $19.00 through $249.00
- Lab Tested
- Fast Shipping
Description
Mitsu Mitragynine + Pseudoindoxyl Tablet
Every unit reflects a focused approach to formulation — clearly labeled, distinctly composed, and presented without inflated claims or unnecessary distraction.
Each tablet delivers 55mg Mitragynine and 8mg Pseudoindoxyl with a blue raspberry profile, clearly labeled compound content, and batch packaged consistency. Mitsu stands apart through its defined composition and confident simplicity.
Related Products
-
- Select options This product has multiple variants. The options may be chosen on the product page
Price range: $8.00 through $200.00 -
- Select options This product has multiple variants. The options may be chosen on the product page
Price range: $30.00 through $250.00 -
- Select options This product has multiple variants. The options may be chosen on the product page
Price range: $7.20 through $180.00 -
- Select options This product has multiple variants. The options may be chosen on the product page
Price range: $28.00 through $225.00
Mitsu MIT & Pseudoindoxyl Tablet Lab Results
Lab Tested By: Infinite Chemical Analysis Labs (InfiniteCAL), CA
Date of Analysis: December 30, 2025
Sample ID: ICC-251229-38-001
Matrix: Concentrate
Tested: 0.79 g
Verified Compound Content (Per Tablet)
- Mitragynine: 51.4 mg
- Mitragynine Pseudoindoxyl: 7.76 mg
- 7 Hydroxymitragynine: Not Detected
Total Kratom Alkaloids: 83.2 mg per serving
- Paynantheine: 8.69 mg
- Speciogynine: 5.75 mg
- Speciociliatine: 8.14 mg
- Corynantheidine: 1.42 mg
This batch of Mitsu tablets has been independently verified for compound identity and concentration by Infinite Chemical Analysis Labs. Laboratory analysis confirms measurable Mitragynine and Mitragynine Pseudoindoxyl levels aligned with labeled formulation targets, with no detectable 7-Hydroxymitragynine. Total alkaloid content reflects a clearly defined, controlled composition consistent with Mitsu’s stated formulation.
IMPORTANT NOTICE
For adult purchasers 21+ only. No directions, dosage information, or recommendations are provided or implied.
Repeated or improper handling may be associated with habit-forming effects or withdrawal-like symptoms.
Individuals who are pregnant or nursing should avoid contact. No medical or therapeutic claims are made. Keep out of reach of children and pets.